Suppr超能文献

在临床指南制定过程中增强患者和公众对健康结局选择的参与:一项民族志研究。

Enhancing patient and public contribution in health outcome selection during clinical guideline development: an ethnographic study.

机构信息

Roche Products Ltd, Welwyn Garden City, UK.

Department of Public Health, Policy and Systems, Institute of Population Health, University of Liverpool, Liverpool, UK.

出版信息

BMC Health Serv Res. 2022 Mar 18;22(1):361. doi: 10.1186/s12913-022-07736-6.

Abstract

BACKGROUND

Patient and public involvement (PPI) is a cornerstone in enhancing healthcare research and delivery, including clinical guideline development. Health outcomes concern changes in the health status of an individual or population that are attributable to an intervention. Discussion of relevant health outcomes impacts the resulting clinical guidelines for practice. This study explores how the input of PPI contributors at the National Institute of Health and Care Excellence (NICE) is integrated into guideline development, particularly in relation to health outcome selection.

METHODS

The study used an ethnographic methodological approach. Data comprised: observations of committee meetings, scoping workshops and training sessions, and in-depth interviews with PPI contributors, health professionals and chairs from clinical guideline development committees. Data were analysed thematically.

RESULTS

PPI contributors' input in the guideline development process was often of limited scope, particularly in selecting health outcomes. Key constraints on their input included: the technical content and language of guidelines, assumed differences in the health-related priorities between PPI contributors and health professionals, and the linear timeline of the guideline development process. However, PPI contributors can influence clinical guideline development including the selection of relevant health outcomes. This was achieved through several factors and highlights the important role of the committee chair, the importance of training and support for all committee members, the use of plain language and the opportunity for all committee members to engage.

CONCLUSIONS

Lay member input during the outcome selection phase of clinical guideline development is achievable, but there are challenges to overcome. Study findings identify ways that future guideline developers can support meaningful lay involvement in guideline development and health outcome selection.

摘要

背景

患者和公众参与(PPI)是增强医疗保健研究和服务的基石,包括临床指南的制定。健康结果是指由于干预而导致个体或人群健康状况发生的变化。讨论相关的健康结果会影响实践的临床指南。本研究探讨了在国家卫生与保健卓越研究所(NICE)中,PPI 参与者的投入是如何融入指南制定的,特别是在健康结果选择方面。

方法

本研究采用了民族志方法学方法。数据包括:对委员会会议、范围界定研讨会和培训课程的观察,以及对 PPI 参与者、卫生专业人员和临床指南制定委员会主席的深入访谈。数据进行了主题分析。

结果

PPI 参与者在指南制定过程中的投入往往范围有限,特别是在选择健康结果方面。对他们投入的主要限制包括:指南的技术内容和语言、PPI 参与者和卫生专业人员之间假定的健康相关优先事项的差异,以及指南制定过程的线性时间表。然而,PPI 参与者可以影响临床指南的制定,包括相关健康结果的选择。这是通过几个因素实现的,突出了委员会主席的重要作用、对所有委员会成员的培训和支持的重要性、使用通俗易懂的语言以及所有委员会成员参与的机会。

结论

在临床指南制定的结果选择阶段,让非专业人士参与是可行的,但仍存在需要克服的挑战。研究结果确定了未来指南制定者可以支持非专业人士在指南制定和健康结果选择方面进行有意义的参与的方法。

相似文献

3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10

本文引用的文献

1
A Critical Discussion of Patient Engagement in Research.关于患者参与研究的批判性讨论
J Patient Cent Res Rev. 2017 Jan 31;4(1):39-41. doi: 10.17294/2330-0698.1273. eCollection 2017 Winter.
7
The COMET Handbook: version 1.0.《COMET手册:第1.0版》
Trials. 2017 Jun 20;18(Suppl 3):280. doi: 10.1186/s13063-017-1978-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验